Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
Study NCT ID:
NCT04286750
Status:
COMPLETED
Last Update Posted:
2021-01-20
First Post:
2020-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239
Sponsor:
Idorsia Pharmaceuticals Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-25
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-25
First Submit QC Date:
None
Study First Post Date:
2020-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-19
Last Update Post Date:
2021-01-20
Last Update Post Date Type:
ACTUAL